Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | ALBERTDAVD Albert David Limited Pharma · Small | AMBALALSA Ambalal Sarabhai Enterprises Limited Pharma · Small | HALEOSLABS HALEOS LABS LIMITED Pharma · Small |
|---|---|---|---|---|
| Final Score | 15 | 23 | 45 | 29 |
| Verdict | OVERVALUED | OVERVALUED | WATCHLIST | OVERVALUED |
| Style | OVERVALUED | OVERVALUED | Financial Turnaround | OVERVALUED |
| Piotroski | 6/9 | 3/9 | 7/9 | 8/9 |
| Valuation | 3/30 | 5/30 | 17/30 | 7/30 |
| Growth | 2/25 | 7/25 | 12/25 | 8/25 |
| Quality | 0/20 | 0/20 | 2/20 | 0/20 |
| Balance Sheet | 6/15 | 10/15 | 7/15 | 9/15 |
| Cash Flow | 4/10 | 3/10 | 5/10 | 3/10 |
| Price | ₹80.24 | ₹710 | ₹34.3 | ₹1,407.9 |
| P/E | 55.60 | — | 14.20 | 23.70 |
| P/B | 1.47 | 1.01 | 1.67 | 1.92 |
| ROE | 2.75% | -0.38% | 12.40% | 8.44% |
| ROCE | 5.58% | 0.77% | 11.50% | 9.91% |
| Debt / Equity | 0.33 | 0.08 | 0.36 | 0.52 |
| FCF Yield | — | — | 1.14% | — |
| Dividend Y | — | 0.72% | — | 0.11% |
| Altman Z | 3.33 | 3.86 | 2.77 | 2.91 |
| Promoter % | 37.71% | 62.23% | 31.36% | 72.10% |
| Mkt Cap (₹Cr) | 221.00 | 396.00 | 264.00 | 410.00 |
| Graham # | ₹40.86 | — | ₹32.87 | ₹953.72 |
| Fair PE | 4.2 | 23.5 | 42.3 | 13.8 |
| MoS % | -1261.3% | — | +65.1% | -77.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startAAREYDRUGS125
ALBERTDAVD50
AMBALALSA97
HALEOSLABS101